{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:11:19Z","timestamp":1794661879960,"version":"4.9.1"},"reference-count":52,"publisher":"American Association for Cancer Research (AACR)","issue":"4","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mutations in the breast cancer susceptibility gene 1 (BRCA1) are associated with an increased risk of developing epithelial ovarian cancer. However, beyond the role of BRCA1 in DNA repair, little is known about other mechanisms by which BRCA1 impairment promotes carcinogenesis. Given that altered metabolism is now recognized as important in the initiation and progression of cancer, we asked whether the loss of BRCA1 changes metabolism in the cells of origin of ovarian cancer. The findings show that silencing BRCA1 in ovarian surface epithelial and fallopian tube cells increased glycolysis. Furthermore, when these cells were transfected with plasmids carrying deleterious BRCA1 mutations (5382insC or the P1749R), there was an increase in hexokinase-2 (HK2), a key glycolytic enzyme. This effect was mediated by MYC and the STAT3. To target the metabolic phenotype induced by loss of BRCA1, a drug-repurposing approach was used and aspirin was identified as an agent that counteracted the increase in HK2 and the increase in glycolysis induced by BRCA1 impairment. Evidence from this study indicates that the tumor suppressor functions of BRCA1 extend beyond DNA repair to include metabolic endpoints and identifies aspirin as an ovarian cancer chemopreventive agent capable of reversing the metabolic derangements caused by loss of BRCA1. Cancer Prev Res; 10(4); 255\u201366. \u00a92017 AACR.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-16-0281","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T21:00:37Z","timestamp":1488834037000},"page":"255-266","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention"],"prefix":"10.1158","volume":"10","author":[{"given":"Tatsuyuki","family":"Chiyoda","sequence":"first","affiliation":[{"name":"1Department of Obstetrics and Gynecology\/Section of Gynecologic Oncology, The University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Hart","sequence":"additional","affiliation":[{"name":"1Department of Obstetrics and Gynecology\/Section of Gynecologic Oncology, The University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Eckert","sequence":"additional","affiliation":[{"name":"1Department of Obstetrics and Gynecology\/Section of Gynecologic Oncology, The University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"McGregor","sequence":"additional","affiliation":[{"name":"2Department of Pathology, The University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo R.","family":"Lastra","sequence":"additional","affiliation":[{"name":"2Department of Pathology, The University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Hamamoto","sequence":"additional","affiliation":[{"name":"3Department of Medicine, Section of Hematology\/Oncology, The University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Nakamura","sequence":"additional","affiliation":[{"name":"3Department of Medicine, Section of Hematology\/Oncology, The University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Diane","family":"Yamada","sequence":"additional","affiliation":[{"name":"1Department of Obstetrics and Gynecology\/Section of Gynecologic Oncology, The University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olufunmilayo I.","family":"Olopade","sequence":"additional","affiliation":[{"name":"3Department of Medicine, Section of Hematology\/Oncology, The University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Lengyel","sequence":"additional","affiliation":[{"name":"1Department of Obstetrics and Gynecology\/Section of Gynecologic Oncology, The University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris L.","family":"Romero","sequence":"additional","affiliation":[{"name":"1Department of Obstetrics and Gynecology\/Section of Gynecologic Oncology, The University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2017,4,2]]},"reference":[{"key":"2022060815325727300_bib1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"key":"2022060815325727300_bib2","volume-title":"SEER Cancer Statistics Review, 1975-2010, National Cancer Institute","author":"Howlader"},{"key":"2022060815325727300_bib3","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"key":"2022060815325727300_bib4","volume-title":"Genetic\/familial high-risk assessment: breast and ovarian","author":"National Comprehensive Cancer Network","year":"2016"},{"key":"2022060815325727300_bib5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary ovarian cancer clinical study group","volume":"339","author":"Narod","year":"1998","journal-title":"N Engl J Med"},{"key":"2022060815325727300_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng953","article-title":"BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair","volume":"32","author":"Hartman","year":"2002","journal-title":"Nat Genet"},{"key":"2022060815325727300_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/35044000","article-title":"In search of the tumour-suppressor functions of BRCA1 and BRCA2","volume":"408","author":"Scully","year":"2000","journal-title":"Nature"},{"key":"2022060815325727300_bib8","volume-title":"The metabolism of tumors: investigations from the Kaiser Wilhelm Institute for Biology, Berlin Dahlem","author":"Warburg","year":"1930"},{"key":"2022060815325727300_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"2022060815325727300_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"2022060815325727300_bib11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"key":"2022060815325727300_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ccell.2015.05.007","article-title":"Broad anti-tumor activity of a small molecule that selectively targets the Warburg effect and lipogenesis","volume":"28","author":"Flaveny","year":"2015","journal-title":"Cancer Cell"},{"key":"2022060815325727300_bib13","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1158\/1078-0432.CCR-14-2198","article-title":"Molecular pathways: trafficking of metabolic resources in the tumor microenvironment","volume":"21","author":"Romero","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2022060815325727300_bib14","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med"},{"key":"2022060815325727300_bib15","doi-asserted-by":"crossref","first-page":"e102438","DOI":"10.1371\/journal.pone.0102438","article-title":"BRCA1 induces major energetic metabolism reprogramming in breast cancer cells","volume":"9","author":"Privat","year":"2014","journal-title":"PLoS One"},{"key":"2022060815325727300_bib16","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1074\/jbc.M504652200","article-title":"BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase","volume":"281","author":"Moreau","year":"2006","journal-title":"J Biol Chem"},{"key":"2022060815325727300_bib17","doi-asserted-by":"crossref","first-page":"dju091","DOI":"10.1093\/jnci\/dju091","article-title":"Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis","volume":"106","author":"Friebel","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2022060815325727300_bib18","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1073\/pnas.1017300108","article-title":"Modeling high-grade serous ovarian carcinogenesis from the fallopian tube","volume":"108","author":"Karst","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060815325727300_bib19","doi-asserted-by":"crossref","first-page":"23548","DOI":"10.18632\/oncotarget.4556","article-title":"Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer","volume":"6","author":"Litchfield","year":"2015","journal-title":"Oncotarget"},{"key":"2022060815325727300_bib20","doi-asserted-by":"crossref","first-page":"479.e1","DOI":"10.1016\/j.ajog.2014.10.026","article-title":"Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models","volume":"212","author":"Lengyel","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"2022060815325727300_bib21","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1128\/MCB.00440-07","article-title":"Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1","volume":"27","author":"Kim","year":"2007","journal-title":"Mol Cell Biol"},{"key":"2022060815325727300_bib22","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1111\/j.1742-4658.2010.07735.x","article-title":"BRCA1 16 years later: risk-associated BRCA1 mutations and their functional implications","volume":"277","author":"Linger","year":"2010","journal-title":"FEBS J"},{"key":"2022060815325727300_bib23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"2022060815325727300_bib24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"2022060815325727300_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrm4007","article-title":"p53 in survival, death and metabolic health: a lifeguard with a licence to kill","volume":"16","author":"Kruiswijk","year":"2015","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2022060815325727300_bib26","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat Commun"},{"key":"2022060815325727300_bib27","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1073\/pnas.96.9.4983","article-title":"BRCA1 interacts with components of the histone deacetylase complex","volume":"96","author":"Yarden","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060815325727300_bib28","doi-asserted-by":"crossref","first-page":"43407","DOI":"10.1074\/jbc.M108181200","article-title":"Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions","volume":"276","author":"Mathupala","year":"2001","journal-title":"J Biol Chem"},{"key":"2022060815325727300_bib29","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1038\/emboj.2012.45","article-title":"A novel miR-155\/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells","volume":"31","author":"Jiang","year":"2012","journal-title":"EMBO J"},{"key":"2022060815325727300_bib30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc1431","article-title":"BRCA1 and BRCA2: 1994 and beyond","volume":"4","author":"Narod","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"2022060815325727300_bib31","doi-asserted-by":"crossref","first-page":"e104521","DOI":"10.1371\/journal.pone.0104521","article-title":"Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis","volume":"9","author":"Habis","year":"2014","journal-title":"PLoS One"},{"key":"2022060815325727300_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/CEJ.0000000000000128","article-title":"Molecular targets of luteolin in cancer","volume":"25","author":"Tuorkey","year":"2016","journal-title":"Eur J Cancer Prev"},{"key":"2022060815325727300_bib33","doi-asserted-by":"crossref","first-page":"13703","DOI":"10.18632\/oncotarget.3800","article-title":"By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice","volume":"6","author":"Dai","year":"2015","journal-title":"Oncotarget"},{"key":"2022060815325727300_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccr.2013.06.014","article-title":"Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer","volume":"24","author":"Patra","year":"2013","journal-title":"Cancer Cell"},{"key":"2022060815325727300_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-3835(01)00667-X","article-title":"Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase","volume":"173","author":"Ko","year":"2001","journal-title":"Cancer Lett"},{"key":"2022060815325727300_bib36","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jtcvs.2012.12.046","article-title":"Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1","volume":"146","author":"Singh","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2022060815325727300_bib37","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1194\/jlr.M043851","article-title":"BRCA1 is a novel regulator of metabolic function in skeletal muscle","volume":"55","author":"Jackson","year":"2014","journal-title":"J Lipid Res"},{"key":"2022060815325727300_bib38","doi-asserted-by":"crossref","first-page":"52974","DOI":"10.18632\/oncotarget.9732","article-title":"Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based \"starvation\" strategies in BRCA1 carriers","volume":"7","author":"Cuyas","year":"2016","journal-title":"Oncotarget"},{"key":"2022060815325727300_bib39","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.celrep.2014.07.053","article-title":"Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth","volume":"8","author":"Wang","year":"2014","journal-title":"Cell Rep"},{"key":"2022060815325727300_bib40","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1242\/jeb.00241","article-title":"Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function","volume":"206","author":"Wilson","year":"2003","journal-title":"J Exp Biol"},{"key":"2022060815325727300_bib41","doi-asserted-by":"crossref","first-page":"43806","DOI":"10.18632\/oncotarget.6245","article-title":"Inhibition of p300 lysine acetyltransferase activity by luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse model","volume":"6","author":"Selvi","year":"2015","journal-title":"Oncotarget"},{"key":"2022060815325727300_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12885-016-2078-7","article-title":"Aspirin inhibits epithelial-to-mesenchymal transition and migration of oncogenic K-ras-expressing non-small cell lung carcinoma cells by down-regulating E-cadherin repressor Slug","volume":"16","author":"Khan","year":"2016","journal-title":"BMC Cancer"},{"key":"2022060815325727300_bib43","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1158\/1940-6207.CAPR-09-0156","article-title":"The monkey, the hen, and the mouse: models to advance ovarian cancer chemoprevention","volume":"2","author":"Lu","year":"2009","journal-title":"Cancer Prev Res"},{"key":"2022060815325727300_bib44","doi-asserted-by":"crossref","first-page":"djt431","DOI":"10.1093\/jnci\/djt431","article-title":"Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the ovarian cancer association consortium","volume":"106","author":"Trabert","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2022060815325727300_bib45","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ygyno.2016.04.543","article-title":"Is aspirin use associated with a decreased risk of ovarian cancer? A systematic review and meta-analysis of observational studies with dose-response analysis","volume":"142","author":"Zhang","year":"2016","journal-title":"Gynecol Oncol"},{"key":"2022060815325727300_bib46","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10552-016-0804-8","article-title":"Aspirin use and the incidence of breast, colon, ovarian, and pancreatic cancers in elderly women in the Iowa women's health study","volume":"27","author":"Vaughan","year":"2016","journal-title":"Cancer Causes Control"},{"key":"2022060815325727300_bib47","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/annonc\/mdu578","article-title":"Low-dose aspirin use and the risk of ovarian cancer in Denmark","volume":"26","author":"Baandrup","year":"2015","journal-title":"Ann Oncol"},{"key":"2022060815325727300_bib48","article-title":"U.S. Preventive Services Task Force evidence syntheses, formerly systematic evidence reviews","volume-title":"Aspirin use for the prevention of colorectal cancer: an updated systematic evidence review for the US Preventive Services Task Force","author":"Chubak","year":"2015"},{"key":"2022060815325727300_bib49","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","article-title":"Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies","volume":"369","author":"Flossmann","year":"2007","journal-title":"Lancet"},{"key":"2022060815325727300_bib50","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"2022060815325727300_bib51","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/annonc\/mdw133","article-title":"Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1\/2 mutation: a multi-study analysis of response rates and safety","volume":"27","author":"Matulonis","year":"2016","journal-title":"Ann Oncol"},{"key":"2022060815325727300_bib52","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1158\/2159-8290.CD-13-0565","article-title":"Glycolysis back in the limelight: systemic targeting of HK2 blocks tumor growth","volume":"3","author":"Ros","year":"2013","journal-title":"Cancer Discov"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/10\/4\/255\/2241854\/255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/10\/4\/255\/2241854\/255.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T11:41:15Z","timestamp":1654688475000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/10\/4\/255\/46632\/Loss-of-BRCA1-in-the-Cells-of-Origin-of-Ovarian"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,1]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,2]]},"published-print":{"date-parts":[[2017,4,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-16-0281","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.22532368.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22532353.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22532350.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22532371","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22532350","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22532362","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22532356","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22532368","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22532359.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22532359","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6546703.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22532356.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22532365.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22532362.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22532353","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22532365","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22532371.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6546703","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,1]]}}}